{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,23]],"date-time":"2026-01-23T09:25:44Z","timestamp":1769160344456,"version":"3.49.0"},"reference-count":57,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2017,11,1]],"date-time":"2017-11-01T00:00:00Z","timestamp":1509494400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"funder":[{"name":"Boehringer Ingelheim Vetmedica GmbH"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Pharmacological Research"],"published-print":{"date-parts":[[2017,11]]},"DOI":"10.1016\/j.phrs.2017.09.006","type":"journal-article","created":{"date-parts":[[2017,9,19]],"date-time":"2017-09-19T03:30:16Z","timestamp":1505791816000},"page":"215-223","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":4,"special_numbering":"PB","title":["Selective glucocorticoid receptor modulation inhibits cytokine responses in a canine model of mild endotoxemia"],"prefix":"10.1016","volume":"125","author":[{"given":"Johann","family":"Bartko","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ulla","family":"Derhaschnig","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tania","family":"Neels","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Gerald H.","family":"Nabozny","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Christian","family":"Harcken","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jost","family":"Leuschner","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Frerich","family":"De Vries","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Bernd","family":"Jilma","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"7","key":"10.1016\/j.phrs.2017.09.006_bib0005","doi-asserted-by":"crossref","first-page":"2777","DOI":"10.1210\/jc.2015-1127","article-title":"Synthetic glucocorticoids and early variations of blood pressure: a population-based cohort study","volume":"100","author":"Fardet","year":"2015","journal-title":"J. Clin. Endocrinol. Metab."},{"issue":"4","key":"10.1016\/j.phrs.2017.09.006_bib0010","doi-asserted-by":"crossref","first-page":"E249","DOI":"10.1152\/ajpendo.00478.2015","article-title":"The glucocorticoid receptor: cause of or cure for obesity?","volume":"310","author":"John","year":"2016","journal-title":"Am. J. Physiol. Endocrinol. Metab."},{"issue":"1","key":"10.1016\/j.phrs.2017.09.006_bib0015","doi-asserted-by":"crossref","first-page":"E84","DOI":"10.1152\/ajpendo.00205.2014","article-title":"11beta-Hydroxysteroid dehydrogenase type 1 shRNA ameliorates glucocorticoid-induced insulin resistance and lipolysis in mouse abdominal adipose tissue","volume":"308","author":"Wang","year":"2015","journal-title":"Am. J. Physiol. Endocrinol. Metab."},{"issue":"11","key":"10.1016\/j.phrs.2017.09.006_bib0020","doi-asserted-by":"crossref","first-page":"4231","DOI":"10.1210\/jc.2014-2177","article-title":"Abnormalities in cortical bone, trabecular plates, and stiffness in postmenopausal women treated with glucocorticoids","volume":"99","author":"Sutter","year":"2014","journal-title":"J. Clin. Endocrinol. Metab."},{"issue":"4","key":"10.1016\/j.phrs.2017.09.006_bib0025","doi-asserted-by":"crossref","first-page":"1535","DOI":"10.1210\/jc.2005-1893","article-title":"Functional characterization of the natural human glucocorticoid receptor (hGR) mutants hGRalphaR477H and hGRalphaG679S associated with generalized glucocorticoid resistance","volume":"91","author":"Charmandari","year":"2006","journal-title":"J. Clin. Endocrinol. Metab."},{"issue":"1","key":"10.1016\/j.phrs.2017.09.006_bib0030","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1111\/j.1476-5381.2010.01199.x","article-title":"Glucocorticosteroids: current and future directions","volume":"163","author":"Barnes","year":"2011","journal-title":"Br. J. Pharmacol."},{"issue":"5","key":"10.1016\/j.phrs.2017.09.006_bib0035","doi-asserted-by":"crossref","first-page":"1360","DOI":"10.1111\/bph.13014","article-title":"An analysis of glucocorticoid receptor-mediated gene expression in BEAS-2B human airway epithelial cells identifies distinct, ligand-directed, transcription profiles with implications for asthma therapeutics","volume":"172","author":"Joshi","year":"2015","journal-title":"Br. J. Pharmacol."},{"issue":"4b","key":"10.1016\/j.phrs.2017.09.006_bib0040","doi-asserted-by":"crossref","first-page":"1124","DOI":"10.1111\/j.1476-5381.2011.01574.x","article-title":"Anti-inflammatory effects of selective glucocorticoid receptor modulators are partially dependent on up-regulation of dual specificity phosphatase 1","volume":"165","author":"Joanny","year":"2012","journal-title":"Br. J. Pharmacol."},{"key":"10.1016\/j.phrs.2017.09.006_bib0045","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1016\/j.pharmthera.2015.05.001","article-title":"Selective glucocorticoid receptor modulation: new directions with non-steroidal scaffolds","volume":"152","author":"Sundahl","year":"2015","journal-title":"Pharmacol. Ther."},{"key":"10.1016\/j.phrs.2017.09.006_bib0050","unstructured":"C. Harcken, H. Razavi, Identification and Optimization of a Series of Non-Steroidal Trifluoromethylcarbinol Glucocorticoid Receptor Agonists, 1240 (2016) 171\u2013183."},{"issue":"4","key":"10.1016\/j.phrs.2017.09.006_bib0055","doi-asserted-by":"crossref","first-page":"1583","DOI":"10.1021\/jm4019178","article-title":"Identification of highly efficacious glucocorticoid receptor agonists with a potential for reduced clinical bone side effects","volume":"57","author":"Harcken","year":"2014","journal-title":"J. Med. Chem."},{"issue":"12","key":"10.1016\/j.phrs.2017.09.006_bib0060","doi-asserted-by":"crossref","first-page":"1318","DOI":"10.1021\/ml500387y","article-title":"Optimization of drug-like properties of nonsteroidal glucocorticoid mimetics and identification of a clinical candidate","volume":"5","author":"Harcken","year":"2014","journal-title":"ACS Med. Chem. Lett."},{"issue":"8","key":"10.1016\/j.phrs.2017.09.006_bib0065","doi-asserted-by":"crossref","first-page":"631","DOI":"10.1038\/nrd1800","article-title":"The ultimate model organism: progress in experimental medicine","volume":"4","author":"Littman","year":"2005","journal-title":"Nat. Rev. Drug Discov."},{"issue":"4","key":"10.1016\/j.phrs.2017.09.006_bib0070","doi-asserted-by":"crossref","first-page":"861","DOI":"10.1177\/039463201302600404","article-title":"Establishment of a low dose canine endotoxemia model to test anti-inflammatory drugs: effects of prednisolone","volume":"26","author":"De Vries","year":"2013","journal-title":"Int. J. Immunopathol. Pharmacol."},{"issue":"12","key":"10.1016\/j.phrs.2017.09.006_bib0075","doi-asserted-by":"crossref","first-page":"2520","DOI":"10.1182\/blood.V76.12.2520.2520","article-title":"Experimental endotoxemia in humans: analysis of cytokine release and coagulation, fibrinolytic, and complement pathways","volume":"76","author":"van Deventer","year":"1990","journal-title":"Blood"},{"issue":"7","key":"10.1016\/j.phrs.2017.09.006_bib0080","doi-asserted-by":"crossref","first-page":"1573","DOI":"10.1111\/j.1476-5381.2010.00873.x","article-title":"Guidelines for reporting experiments involving animals: the ARRIVE guidelines","volume":"160","author":"McGrath","year":"2010","journal-title":"Br. J. Pharmacol."},{"issue":"7","key":"10.1016\/j.phrs.2017.09.006_bib0085","doi-asserted-by":"crossref","first-page":"1577","DOI":"10.1111\/j.1476-5381.2010.00872.x","article-title":"Animal research: reporting in vivo experiments: the ARRIVE guidelines","volume":"160","author":"Kilkenny","year":"2010","journal-title":"Br. J. Pharmacol."},{"issue":"10","key":"10.1016\/j.phrs.2017.09.006_bib0090","doi-asserted-by":"crossref","first-page":"E846","DOI":"10.1152\/ajpendo.00541.2015","article-title":"Thyroid hormone receptor-beta1 signaling is critically involved in regulating secondary ossification via promoting transcription of the Ihh gene in the epiphysis","volume":"310","author":"Xing","year":"2016","journal-title":"Am. J. Physiol. Endocrinol. Metab."},{"key":"10.1016\/j.phrs.2017.09.006_bib0095","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1016\/j.ejphar.2013.10.008","article-title":"The cellular mechanisms of the antiemetic action of dexamethasone and related glucocorticoids against vomiting","volume":"722","author":"Chu","year":"2014","journal-title":"Eur. J. Pharmacol."},{"issue":"4","key":"10.1016\/j.phrs.2017.09.006_bib0100","first-page":"320","article-title":"Glucocorticoids and control of glomerular filtration rate","volume":"10","author":"Baylis","year":"1990","journal-title":"Semin. Nephrol."},{"key":"10.1016\/j.phrs.2017.09.006_bib0105","series-title":"Canine Hyperadrenocorticism (Cushing\u2019s Syndrome), Canine and Feline Endocrinology and Reproduction","author":"Feldman","year":"2004"},{"issue":"8","key":"10.1016\/j.phrs.2017.09.006_bib0110","doi-asserted-by":"crossref","first-page":"1310","DOI":"10.2460\/ajvr.1981.42.08.1310","article-title":"Sequential morphologic and clinicopathologic alterations in dogs with experimentally induced glucocorticoid hepatopathy","volume":"42","author":"Badylak","year":"1981","journal-title":"Am. J. Vet. Res."},{"issue":"4","key":"10.1016\/j.phrs.2017.09.006_bib0115","doi-asserted-by":"crossref","first-page":"541","DOI":"10.1111\/j.1939-165x.2012.00473.x","article-title":"Estimates of biological variation in routinely measured biochemical analytes in clinically healthy dogs","volume":"41","author":"Ruaux","year":"2012","journal-title":"Vet. Clin. Pathol."},{"issue":"3","key":"10.1016\/j.phrs.2017.09.006_bib0120","doi-asserted-by":"crossref","first-page":"1845","DOI":"10.4049\/jimmunol.178.3.1845","article-title":"Prednisolone dose-dependently influences inflammation and coagulation during human endotoxemia","volume":"178","author":"de Kruif","year":"2007","journal-title":"J. Immunol."},{"issue":"2","key":"10.1016\/j.phrs.2017.09.006_bib0125","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1023\/A:1006071211779","article-title":"Physiological levels of C-reactive protein in normal canine sera","volume":"22","author":"Otabe","year":"1998","journal-title":"Vet. Res. Commun."},{"issue":"10","key":"10.1016\/j.phrs.2017.09.006_bib0130","doi-asserted-by":"crossref","first-page":"1952","DOI":"10.1373\/clinchem.2006.069823","article-title":"The C-reactive protein (+)1444C\/T alteration modulates the inflammation and coagulation response in human endotoxemia","volume":"52","author":"Marsik","year":"2006","journal-title":"Clin. Chem."},{"issue":"5","key":"10.1016\/j.phrs.2017.09.006_bib0135","doi-asserted-by":"crossref","first-page":"1136","DOI":"10.1097\/01.CCM.0000126265.08175.BE","article-title":"Effect of interleukin-6 blockade on tissue factor-induced coagulation in human endotoxemia","volume":"32","author":"Derhaschnig","year":"2004","journal-title":"Crit. Care Med."},{"issue":"3 Pt 2","key":"10.1016\/j.phrs.2017.09.006_bib0140","first-page":"R527","article-title":"Multiple mechanisms mediate antipyretic action of glucocorticoids","volume":"269","author":"Coelho","year":"1995","journal-title":"Am. J. Physiol."},{"issue":"Suppl. 5","key":"10.1016\/j.phrs.2017.09.006_bib0145","doi-asserted-by":"crossref","first-page":"S168","DOI":"10.1086\/317522","article-title":"Pyrogen sensing and signaling: old views and new concepts","volume":"31","author":"Blatteis","year":"2000","journal-title":"Clin. Infect. Dis."},{"issue":"4","key":"10.1016\/j.phrs.2017.09.006_bib0150","doi-asserted-by":"crossref","first-page":"449","DOI":"10.1001\/archinte.160.4.449","article-title":"Antipyretic therapy: physiologic rationale, diagnostic implications, and clinical consequences","volume":"160","author":"Plaisance","year":"2000","journal-title":"Arch. Intern. Med."},{"issue":"1","key":"10.1016\/j.phrs.2017.09.006_bib0155","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1016\/S0009-9236(99)70053-6","article-title":"Acetaminophen has greater antipyretic efficacy than aspirin in endotoxemia: a randomized, double-blind, placebo-controlled trial","volume":"66","author":"Pernerstorfer","year":"1999","journal-title":"Clin. Pharmacol. Ther."},{"issue":"11","key":"10.1016\/j.phrs.2017.09.006_bib0160","doi-asserted-by":"crossref","first-page":"E994","DOI":"10.1152\/ajpendo.00345.2014","article-title":"Hypothalamic-pituitary-adrenal axis in lethal canine Staphylococcus aureus pneumonia","volume":"307","author":"Cortes-Puch","year":"2014","journal-title":"Am. J. Physiol. Endocrinol. Metab."},{"issue":"3","key":"10.1016\/j.phrs.2017.09.006_bib0165","doi-asserted-by":"crossref","first-page":"512","DOI":"10.1097\/01.CCM.0000155908.46346.ED","article-title":"Decreased physiologic variability as a generalized response to human endotoxemia","volume":"33","author":"Rassias","year":"2005","journal-title":"Crit. Care Med."},{"issue":"8","key":"10.1016\/j.phrs.2017.09.006_bib0170","doi-asserted-by":"crossref","first-page":"476","DOI":"10.1007\/BF03348004","article-title":"Blunted cortisol response after administration of corticotropin releasing hormone in endotoxemic dogs","volume":"20","author":"Moeniralam","year":"1997","journal-title":"J. Endocrinol. Invest."},{"issue":"4","key":"10.1016\/j.phrs.2017.09.006_bib0175","doi-asserted-by":"crossref","first-page":"304","DOI":"10.1002\/j.1552-4604.1997.tb04307.x","article-title":"Cortisol pharmacodynamics after methylprednisolone administration in young and elderly males","volume":"37","author":"Tornatore","year":"1997","journal-title":"J. Clin. Pharmacol."},{"issue":"11","key":"10.1016\/j.phrs.2017.09.006_bib0180","doi-asserted-by":"crossref","first-page":"e309","DOI":"10.1097\/CCM.0b013e31828a45ef","article-title":"Targeting dexamethasone to macrophages in a porcine endotoxemic model","volume":"41","author":"Granfeldt","year":"2013","journal-title":"Crit. Care Med."},{"issue":"1","key":"10.1016\/j.phrs.2017.09.006_bib0185","doi-asserted-by":"crossref","first-page":"15","DOI":"10.5414\/CP201938","article-title":"Comparison of methods for evaluation of the suppressive effects of prednisolone on the HPA axis and bone turnover: changes in s-DHEAS are as sensitive as the ACTH test","volume":"52","author":"Gruvstad","year":"2014","journal-title":"Int. J. Clin. Pharmacol. Ther."},{"key":"10.1016\/j.phrs.2017.09.006_bib0190","doi-asserted-by":"crossref","first-page":"896","DOI":"10.1016\/j.phrs.2016.08.010","article-title":"Six months of resveratrol supplementation has no measurable effect in type 2 diabetic patients. A randomized, double blind, placebo-controlled trial","volume":"111","author":"Bo","year":"2016","journal-title":"Pharmacol. Res."},{"issue":"3","key":"10.1016\/j.phrs.2017.09.006_bib0195","doi-asserted-by":"crossref","first-page":"E587","DOI":"10.1152\/ajpendo.00219.2016","article-title":"Cortical bone loss caused by glucocorticoid excess requires RANKL production by osteocytes and is associated with reduced OPG expression in mice","volume":"311","author":"Piemontese","year":"2016","journal-title":"Am. J. Physiol. Endocrinol. Metab."},{"issue":"3","key":"10.1016\/j.phrs.2017.09.006_bib0200","doi-asserted-by":"crossref","first-page":"459","DOI":"10.1530\/EJE-11-0751","article-title":"Prednisone affects inflammation, glucose tolerance, and bone turnover within hours of treatment in healthy individuals","volume":"166","author":"Kauh","year":"2012","journal-title":"Eur. J. Endocrinol."},{"issue":"1","key":"10.1016\/j.phrs.2017.09.006_bib0205","doi-asserted-by":"crossref","first-page":"126","DOI":"10.2460\/ajvr.1993.54.01.126","article-title":"Effects of orally administered prednisone on glucose tolerance and insulin secretion in clinically normal dogs","volume":"54","author":"Moore","year":"1993","journal-title":"Am. J. Vet. Res."},{"issue":"1","key":"10.1016\/j.phrs.2017.09.006_bib0210","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1016\/S2213-8587(13)70045-7","article-title":"Glucocorticoid-induced osteoporosis: mechanisms, management, and future perspectives","volume":"1","author":"Seibel","year":"2013","journal-title":"Lancet Diabetes Endocrinol."},{"issue":"6","key":"10.1016\/j.phrs.2017.09.006_bib0215","doi-asserted-by":"crossref","first-page":"583","DOI":"10.1111\/j.1365-2885.2010.01174.x","article-title":"Bone demineralization in the lumbar spine of dogs submitted to prednisone therapy","volume":"33","author":"Costa","year":"2010","journal-title":"J. Vet. Pharmacol. Ther."},{"issue":"2","key":"10.1016\/j.phrs.2017.09.006_bib0220","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1046\/j.1439-0442.2003.00493.x","article-title":"Influence of cortisol, gonadal steroids and an energy deficit on biochemical indicators of bone turnover in Swine","volume":"50","author":"Weiler","year":"2003","journal-title":"J. Vet. Med. A Physiol. Pathol. Clin. Med."},{"issue":"1","key":"10.1016\/j.phrs.2017.09.006_bib0225","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1002\/jbmr.5650030117","article-title":"Effect of short-term glucocorticoids on serum osteocalcin in healthy young men","volume":"3","author":"Godschalk","year":"1988","journal-title":"J. Bone Miner. Res."},{"issue":"1 Pt 1","key":"10.1016\/j.phrs.2017.09.006_bib0230","first-page":"E136","article-title":"Prednisone-induced osteopenia in beagles: variable effects mediated by differential suppression of bone formation","volume":"263","author":"Quarles","year":"1992","journal-title":"Am. J. Physiol."},{"key":"10.1016\/j.phrs.2017.09.006_bib0235","series-title":"Therapeutic Drugs","author":"Dollery","year":"1999"},{"issue":"Suppl. 2","key":"10.1016\/j.phrs.2017.09.006_bib0240","doi-asserted-by":"crossref","first-page":"S2","DOI":"10.1186\/ar4686","article-title":"The value of glucocorticoid co-therapy in different rheumatic diseases\u2014positive and adverse effects","volume":"16","author":"van der Goes","year":"2014","journal-title":"Arthritis Res. Ther."},{"issue":"3","key":"10.1016\/j.phrs.2017.09.006_bib0245","doi-asserted-by":"crossref","first-page":"849","DOI":"10.1021\/jm401616g","article-title":"Glucocorticoid receptor modulators informed by crystallography lead to a new rationale for receptor selectivity, function, and implications for structure-based design","volume":"57","author":"Carson","year":"2014","journal-title":"J. Med. Chem."},{"issue":"49","key":"10.1016\/j.phrs.2017.09.006_bib0250","doi-asserted-by":"crossref","first-page":"19244","DOI":"10.1073\/pnas.0705517104","article-title":"Antiinflammatory glucocorticoid receptor ligand with reduced side effects exhibits an altered protein\u2013protein interaction profile","volume":"104","author":"Miner","year":"2007","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"issue":"5","key":"10.1016\/j.phrs.2017.09.006_bib0255","doi-asserted-by":"crossref","first-page":"2080","DOI":"10.1210\/en.2007-1353","article-title":"LGD-5552, an antiinflammatory glucocorticoid receptor ligand with reduced side effects, in vivo","volume":"149","author":"Lopez","year":"2008","journal-title":"Endocrinology"},{"issue":"4","key":"10.1016\/j.phrs.2017.09.006_bib0260","doi-asserted-by":"crossref","first-page":"2608","DOI":"10.4049\/jimmunol.180.4.2608","article-title":"A plant-derived ligand favoring monomeric glucocorticoid receptor conformation with impaired transactivation potential attenuates collagen-induced arthritis","volume":"180","author":"Dewint","year":"2008","journal-title":"J. Immunol."},{"issue":"10","key":"10.1016\/j.phrs.2017.09.006_bib0265","doi-asserted-by":"crossref","first-page":"3719","DOI":"10.1210\/en.2012-2221","article-title":"Effects of the selective glucocorticoid receptor modulator compound A on bone metabolism and inflammation in male mice with collagen-induced arthritis","volume":"154","author":"Rauner","year":"2013","journal-title":"Endocrinology"},{"issue":"22","key":"10.1016\/j.phrs.2017.09.006_bib0270","doi-asserted-by":"crossref","first-page":"2442","DOI":"10.1001\/jama.2016.5444","article-title":"Polymyalgia rheumatica and giant cell arteritis: a systematic review","volume":"315","author":"Buttgereit","year":"2016","journal-title":"JAMA"},{"issue":"3","key":"10.1016\/j.phrs.2017.09.006_bib0275","doi-asserted-by":"crossref","first-page":"565","DOI":"10.1378\/chest.11-1152","article-title":"A unified front against COPD: clinical practice guidelines from the American College of Physicians, the American College of Chest Physicians, the American Thoracic Society, and the European Respiratory Society","volume":"140","author":"Hanania","year":"2011","journal-title":"Chest"},{"issue":"5","key":"10.1016\/j.phrs.2017.09.006_bib0280","doi-asserted-by":"crossref","first-page":"617","DOI":"10.1016\/j.autrev.2012.12.001","article-title":"The use of glucocorticoids in systemic lupus erythematosus. After 60 years still more an art than science","volume":"12","author":"Luijten","year":"2013","journal-title":"Autoimmun. Rev."},{"issue":"5","key":"10.1016\/j.phrs.2017.09.006_bib0285","doi-asserted-by":"crossref","first-page":"865","DOI":"10.1111\/bcp.12857","article-title":"Dissociation between systemic and pulmonary anti-inflammatory effects of dexamethasone in humans","volume":"81","author":"Bartko","year":"2016","journal-title":"Br. J. Clin. Pharmacol."}],"container-title":["Pharmacological Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1043661817307545?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1043661817307545?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,6,25]],"date-time":"2025-06-25T20:09:24Z","timestamp":1750882164000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1043661817307545"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,11]]},"references-count":57,"alternative-id":["S1043661817307545"],"URL":"https:\/\/doi.org\/10.1016\/j.phrs.2017.09.006","relation":{},"ISSN":["1043-6618"],"issn-type":[{"value":"1043-6618","type":"print"}],"subject":[],"published":{"date-parts":[[2017,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Selective glucocorticoid receptor modulation inhibits cytokine responses in a canine model of mild endotoxemia","name":"articletitle","label":"Article Title"},{"value":"Pharmacological Research","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.phrs.2017.09.006","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2017 Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}]}}